Partners say fermentation breakthrough will allow consumers to enjoy products using Reb M at a commercially viable price.
Evolva Holding SA, Reinach, Switzerland, said its patent application on a process to efficiently and sustainably produce next-generation sweeteners via fermentation, including Rebaudioside M (“Reb M”), has now published.
The patent application was originally filed on February 6, 2013. Cargill Incorporated and Evolva announced in late 2013 that they were ahead of schedule and moving into pilot scale testing to produce fermentation-based steviol glycosides. This year, on May 21, 2014, the companies announced that a key technical milestone had been met.